Heron Therapeutics, Inc. (HRTX) Forms $29.85 Double Top; E*TRADE Financial (ETFC) Covered By 22 Bullish Analysts Last Week

E*TRADE Financial Corporation (NASDAQ:ETFC) Logo

Heron Therapeutics, Inc. (HRTX) formed double top with $31.04 target or 4.00% above today’s $29.85 share price. Heron Therapeutics, Inc. (HRTX) has $2.11 billion valuation. The stock increased 1.53% or $0.45 during the last trading session, reaching $29.85. About 282,640 shares traded. Heron Therapeutics, Inc. (NASDAQ:HRTX) has risen 87.03% since April 12, 2017 and is uptrending. It has outperformed by 75.48% the S&P500.

Among 24 analysts covering E*TRADE (NASDAQ:ETFC), 22 have Buy rating, 0 Sell and 2 Hold. Therefore 92% are positive. E*TRADE had 94 analyst reports since July 24, 2015 according to SRatingsIntel. Jefferies maintained E*TRADE Financial Corporation (NASDAQ:ETFC) rating on Tuesday, October 3. Jefferies has “Hold” rating and $43.0 target. The firm earned “Buy” rating on Friday, January 8 by Deutsche Bank. The firm earned “Outperform” rating on Wednesday, September 21 by Credit Suisse. The rating was maintained by Credit Suisse on Monday, February 22 with “Outperform”. SunTrust maintained it with “Buy” rating and $65.0 target in Friday, January 26 report. Deutsche Bank maintained E*TRADE Financial Corporation (NASDAQ:ETFC) on Thursday, March 17 with “Buy” rating. The firm has “Hold” rating by Keefe Bruyette & Woods given on Friday, October 6. The stock has “Overweight” rating by Barclays Capital on Thursday, October 13. The firm earned “Buy” rating on Thursday, December 14 by SunTrust. The stock of E*TRADE Financial Corporation (NASDAQ:ETFC) earned “Mkt Perform” rating by Keefe Bruyette & Woods on Thursday, December 8. See E*TRADE Financial Corporation (NASDAQ:ETFC) latest ratings:

10/04/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $64 New Target: $67 Maintain
10/04/2018 Broker: Bernstein Rating: Outperform New Target: $67 Initiates Coverage On
06/04/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $62 New Target: $63 Maintain
29/03/2018 Broker: JMP Securities Old Rating: Market Outperform New Rating: Market Outperform Old Target: $58 New Target: $60 Maintain
14/03/2018 Broker: Sandler O’Neill Rating: Hold New Target: $58.0 Maintain
12/03/2018 Broker: Raymond James Old Rating: Outperform New Rating: Strong Buy Upgrade
06/03/2018 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $61.0 Upgrade
06/03/2018 Broker: Wood Old Rating: Market Perform New Rating: Outperform New Target: $61 Upgrade
12/02/2018 Broker: SunTrust Rating: Buy New Target: $66.0 Maintain
30/01/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $63 New Target: $64 Maintain

The stock increased 1.23% or $0.7 during the last trading session, reaching $57.82. About 428,835 shares traded. E*TRADE Financial Corporation (NASDAQ:ETFC) has risen 61.16% since April 12, 2017 and is uptrending. It has outperformed by 49.61% the S&P500.

Since January 30, 2018, it had 0 insider buys, and 6 selling transactions for $12.52 million activity. Another trade for 2,000 shares valued at $105,500 was made by SCLAFANI JOSEPH L on Tuesday, January 30. Curcio Michael John had sold 34,158 shares worth $1.77M. Shares for $407,040 were sold by Simonich Brent on Tuesday, March 6. Roessner Karl A sold $5.96 million worth of stock or 115,059 shares. LAWSON RODGER A sold $675,418 worth of E*TRADE Financial Corporation (NASDAQ:ETFC) on Wednesday, February 7. On Wednesday, February 7 the insider Pizzi Michael A. sold $3.60M.

Investors sentiment decreased to 0.96 in 2017 Q4. Its down 0.14, from 1.1 in 2017Q3. It is negative, as 37 investors sold E*TRADE Financial Corporation shares while 161 reduced holdings. 67 funds opened positions while 124 raised stakes. 238.15 million shares or 3.07% less from 245.70 million shares in 2017Q3 were reported. Andra Ap holds 0.09% of its portfolio in E*TRADE Financial Corporation (NASDAQ:ETFC) for 79,800 shares. Robeco Institutional Asset Bv holds 402,748 shares. Westfield Cap Limited Partnership reported 0.31% of its portfolio in E*TRADE Financial Corporation (NASDAQ:ETFC). Aqr Capital Management Ltd has invested 0.01% in E*TRADE Financial Corporation (NASDAQ:ETFC). Thrivent Fin For Lutherans owns 3.60 million shares. Benjamin F Edwards & Inc has 0% invested in E*TRADE Financial Corporation (NASDAQ:ETFC). Ssi has invested 0.02% of its portfolio in E*TRADE Financial Corporation (NASDAQ:ETFC). Kentucky Retirement Fund owns 7,189 shares. Moreover, Stevens Cap Mgmt Lp has 0.04% invested in E*TRADE Financial Corporation (NASDAQ:ETFC). Wedge Cap Mngmt L Ltd Partnership Nc stated it has 0.01% in E*TRADE Financial Corporation (NASDAQ:ETFC). Engineers Gate Manager L P owns 9,606 shares or 0.03% of their US portfolio. Ballentine Prtnrs Ltd Liability Corporation stated it has 0.01% of its portfolio in E*TRADE Financial Corporation (NASDAQ:ETFC). New Mexico Educational Retirement Board reported 26,404 shares stake. The Wisconsin-based Mason Street Advisors Limited Liability Company has invested 0.04% in E*TRADE Financial Corporation (NASDAQ:ETFC). California State Teachers Retirement reported 460,562 shares stake.

E*TRADE Financial Corporation, a financial services company, provides brokerage and related services and products primarily to individual retail investors under the E*TRADE Financial brand. The company has market cap of $15.33 billion. It also offers investor-focused banking products, primarily deposits to retail investors; and financial corporate services, such as software and services for managing equity compensation plans to its corporate clients. It has a 26.89 P/E ratio. The firm provides its services to clients through digital platforms; and a network of customer service representatives and financial consultants through phone, email, and online at two branches, as well as in person through 30 branches across the United States.

Among 15 analysts covering Heron Therapeutics (NASDAQ:HRTX), 15 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Heron Therapeutics has $58 highest and $22 lowest target. $41.57’s average target is 39.26% above currents $29.85 stock price. Heron Therapeutics had 42 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, March 19 by Needham. The company was maintained on Monday, August 10 by Brean Capital. The stock has “Buy” rating by Cowen & Co on Monday, November 6. The firm has “Buy” rating given on Friday, January 5 by Cantor Fitzgerald. The rating was maintained by Cowen & Co on Thursday, August 3 with “Buy”. As per Wednesday, September 23, the company rating was maintained by Leerink Swann. Mizuho maintained the stock with “Buy” rating in Tuesday, November 7 report. The stock of Heron Therapeutics, Inc. (NASDAQ:HRTX) earned “Buy” rating by Jefferies on Thursday, July 13. The firm earned “Buy” rating on Wednesday, September 2 by Bank of America. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, January 31.

E*TRADE Financial Corporation (NASDAQ:ETFC) Institutional Positions Chart